{"id":1010764,"date":"2026-10-15T16:40:50","date_gmt":"2026-10-15T20:40:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"modified":"2026-10-15T16:40:50","modified_gmt":"2026-10-15T20:40:50","slug":"myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","title":{"rendered":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SALT LAKE CITY, Oct.  15, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p0otS-Qya_lRzyaHJCbR0m_jvQl8ezFqtJKy7efOykpDs412_PciWpreTg1TFjCLqqJxmJ0zBi7t8Hb81kr9W-VYMTmKLbGHzmNvTguxDf8=\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc.<\/a>, (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4:30 pm ET on Wednesday, November 4, 2026. The company\u2019s quarterly earnings will be released the same day after market close. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the third quarter 2026.<\/p>\n<p>A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fzqvlTdUANz0p_tVEbZ8lz8cARlQMfSAwNqvYKu8m5CSqlrmAwGkHRkttx0-W3nbm2a6qw_T9FhSwUzDIwEn35VDVacd57sn_n6NYhRYbRtYpfOEh6y-_g_P-iSP1jqCzYX46wiW2PQv-dxg1jJSp-Qd6xuppQF_V-gjputbbzag8udDMdFwmziwlkCr5S_YkHbekrb5poCUvG09zo2zhgZM8-fe2I0H_6rw5fOfC4KnhzAldzLACJ5wcxe2R0FMZEDnQo2Nw_ExGdv0YdL4WA==\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>. To participate in the live conference call via telephone, please register\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e5RXl20-x-ye_oBtYDyiThu8ZNO-6Jm2v_nfqI5k8NbsFn4Gpje-lQquAgIvOL24uk3avKDTcavBDdaHtjC35ILrcHALH7DRNN6Dn-TA-JvhmGmeu4dgfstIxobE8tOwYRCB9RP-mQtHhWi85YKyb3z1sK_6_yDN-5Xj4zyanVc=\" rel=\"nofollow\" target=\"_blank\">here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fzqvlTdUANz0p_tVEbZ8lzBACPtp-66Pm4hiDo_IMXKAyNCijP5c1PuFt97FsfRUS3a-yuez5vlondg2JuU7YNZk22-rvNirI-DZgyL5s3amwiEIBLgygn0oLHNA2Wopkf9lvoX6Gvm5qNi0tHKw-zlGc2zCQuvgk_wHo9qR7X4Ngrm4kBvZ2O89GDVZkyK64Dty6n6j5ziwyDnk59_JM6QOsVqfLc67jVOq-JnOuYvCKUU9pYSC8RcbzDmAHF7EHl17nuOKGQswE5D-YwjdUw==\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a> following the call.<\/p>\n<p>\n        <strong>About Myriad Genetics\u00a0<\/strong><br \/>\n        <br \/>Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iSp2zIybCLd-mGTu8JA6OxNI64LyXgg5F4ipwCENgcc56F2XlMs_i1NEEeN3lF4sdQebWDiSGSQwr77Iak3idg==\" rel=\"nofollow\" target=\"_blank\">myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong>\u00a0<br \/>Matt Scalo<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ts6Y1a_yIVXImuJ3bJpl0Zml8m5e3GLEcgGRKw7mWI_lXKBPmrFOdSHi4hsboAd9oYWb44rFTFFHseaot5Xycg==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact<\/strong>\u00a0<br \/>Andria Rosell<br \/>(385) 202-3510<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tIKctnzVWOdiFbmJzTWZTCLajIxdY1ROFC75mY-bdOn2xtd63VMhh3_HeAoqg0WYfHfS0IXk9fvX7tM6ko75XQ==\" rel=\"nofollow\" target=\"_blank\"><u>PR@myriad.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDg2N2VhNWUtZWNjMy00ODRiLTljMmMtNzY5MDBjYzJmMzk0LTEwMTk0NjAtMjAyNi0xMC0xNS1lbg==\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4:30 pm ET on Wednesday, November 4, 2026. The company\u2019s quarterly earnings will be released the same day after market close. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the third quarter 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register\u00a0here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010764","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4:30 pm ET on Wednesday, November 4, 2026. The company\u2019s quarterly earnings will be released the same day after market close. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the third quarter 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register\u00a0here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An &hellip; Continue reading &quot;Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T20:40:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026\",\"datePublished\":\"2026-10-15T20:40:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"wordCount\":243,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"name\":\"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\",\"datePublished\":\"2026-10-15T20:40:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","og_description":"SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4:30 pm ET on Wednesday, November 4, 2026. The company\u2019s quarterly earnings will be released the same day after market close. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the third quarter 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register\u00a0here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An &hellip; Continue reading \"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-15T20:40:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026","datePublished":"2026-10-15T20:40:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"wordCount":243,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","name":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=","datePublished":"2026-10-15T20:40:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjU3MSM3ODk4MDMxIzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010764"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010764\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}